Thrombolytic therapy in treatment: summary of an NIH Consensus Conference.
D000208:Acute Disease; D010450:Endopeptidases / Q000627:therapeutic use*; D006801:Humans; D008991:Monitoring, Physiologic; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012306:Risk; D013300:Streptokinase / Q000009:adverse effects* / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D010450:Endopeptidases; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator